Trial intelligence / Profile preview

Melatonin vs Mirtazapine for Emergence Agitation After Nasal Surgery

NCT04908605Phase 4Completed

Sponsor
Ain Shams University
Start
Jun 2021
Primary completion
Mar 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in Emergence agitation (EA) comparing Mirtazapine group, Melatonin group and Placebo group (3 arms). Primary endpoint: Total number of patients with the Riker sedation-agitation score ≥5. Started Jun 2021; status: completed.

02

Drugs

melatoninmirtazapine
03

Conditions

Emergence agitation (EA)

Beyond the preview

Go deeper on NCT04908605.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04908605.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call